Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sanara MedTech Inc.SMTI · Entity 5880 | Director | June 04, 2026 | June 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sanara MedTech Inc.
Report date June 04, 2026 · Filed June 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,415 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 4,616 · Balance 25,415 F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EXXON MOBIL CORP
Report date March 01, 2019 · Filed March 04, 2019
Section 16 reporting ended · disclosed 2019-03-04. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 6, 2026 00:31 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 4,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-027591 · ownership.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,415 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. Read SEC document |
| May 22, 2025 Filed May 27, 2025 22:09 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 3,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-012549 · ownership.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,799 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 21:46 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 3,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-023963 · ownership.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,522 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:22 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-020178 · ownership.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,082 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:00 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 4,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-018951 · ownership.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,280 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:26 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004101 · ownership.xml · nonDerivative · entry 2 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,481 F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:26 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 4,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004101 · ownership.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 17:27 UTC | EXXON MOBIL CORP XOM · Entity 32533 | GrantCommon Stock | 42,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-034799 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,983 F1 · price: Grant of restricted stock units to be settled in shares only. F2 · balance_after: Direct shareholdings include 35,461 shares in joint ownership with reporting person's spouse. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 19:13 UTC | EXXON MOBIL CORP XOM · Entity 32533 | Tax withholdingCommon Stock | 6,178 | $76.73 | $474,022.50 |
DisclosureSEC source: 0001127602-18-034586 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,883 F1 · balance_after: Direct shareholdings include 35,461 shares in joint ownership with reporting person's spouse. Read SEC document |
| December 18, 2017 Filed Dec 19, 2017 22:18 UTC | EXXON MOBIL CORP XOM · Entity 32533 | GiftCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-035183 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,061 F1 · price: No consideration received. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 18:53 UTC | EXXON MOBIL CORP XOM · Entity 32533 | Tax withholdingCommon Stock | 6,298 | $81.67 | $514,326.17 |
DisclosureSEC source: 0001127602-17-033628 · form4.xml · nonDerivative · entry 2 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,061 F2 · balance_after: Direct shareholdings include 29,059 shares in joint ownership with reporting person's spouse. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 18:53 UTC | EXXON MOBIL CORP XOM · Entity 32533 | GrantCommon Stock | 42,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-033628 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,359 F1 · price: Grant of restricted stock units to be settled in shares only. Read SEC document |
| May 18, 2017 Filed Jun 13, 2017 13:19 UTC | EXXON MOBIL CORP XOM · Entity 32533 | GiftCommon Stock | 51,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-021250 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust of Parent Disclosed balance after: 51,425 F1 · price: No consideration received. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:30 UTC | EXXON MOBIL CORP XOM · Entity 32533 | SaleCommon Stock | 5,000 | $90.88 | $454,384.00 |
DisclosureSEC source: 0001127602-16-070387 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,259 F1 · price: Actual sale prices range from $90.87 to $90.88 per share. The number of shares sold at each separate price will be provided upon request. F2 · balance_after: Direct shareholdings include 29,059 shares in joint ownership with reporting person's spouse. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 20:28 UTC | EXXON MOBIL CORP XOM · Entity 32533 | Tax withholdingCommon Stock | 5,202 | $87.70 | $456,189.39 |
DisclosureSEC source: 0001127602-16-068968 · form4.xml · nonDerivative · entry 2 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,259 F2 · balance_after: Direct shareholdings include 20,472 shares in joint ownership with reporting person's spouse. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 20:28 UTC | EXXON MOBIL CORP XOM · Entity 32533 | GrantCommon Stock | 39,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-068968 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,461 F1 · price: Grant of restricted stock units to be settled in shares only. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 20:15 UTC | EXXON MOBIL CORP XOM · Entity 32533 | Tax withholdingCommon Stock | 3,261 | $86.70 | $282,728.70 |
DisclosureSEC source: 0001127602-16-068577 · form4.xml · nonDerivative · entry 1 Ortwein Sara N · CIK 0001688411 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,361 F1 · balance_after: Direct shareholdings include 20,472 shares in joint ownership with reporting person's spouse. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.